Revogene, For In Vitro Diagnostic use in performing nucleic acid testing in clinical laboratories...
FDA Device Recall #Z-0836-2022 — Class II — February 15, 2022
Recall Summary
| Recall Number | Z-0836-2022 |
| Classification | Class II — Moderate risk |
| Date Initiated | February 15, 2022 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Meridian Bioscience Inc |
| Location | Cincinnati, OH |
| Product Type | Devices |
| Quantity | 452 units (398 US, 54 OUS) |
Product Description
Revogene, For In Vitro Diagnostic use in performing nucleic acid testing in clinical laboratories. Meridian branded Revogene: Catalog Number 610210 GenePOC branded Revogene: Catalog Number 130840
Reason for Recall
The photomultiplier tube, may have compromised functionality in some instruments. As a result, the user is likely to observe an increase in false-positive or indeterminate results.
Distribution Pattern
Worldwide distribution - US Nationwide distribution in the states of AK, AL, AR, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, ME, MI, MN, MO, MS, MT, NC, NE, NJ, NV, NY, OH, OR, PA, PR, RI, SD, TN, TX, UT, VA, VT, WI, WV and the countries of Australia, Chile, Italy, Switzerland.
Lot / Code Information
UDI: 00840733102318 All units in the field, all serial numbers.
Other Recalls from Meridian Bioscience Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1019-2026 | Class II | Revogene C. difficile, in vitro diagnostic assa... | Dec 5, 2025 |
| Z-0568-2026 | Class II | Meridian Bioscience, alethia c. Difficile, Cat... | Oct 7, 2025 |
| Z-0569-2026 | Class II | Meridian Bioscience, Group B Streptococcus, Cat... | Oct 7, 2025 |
| Z-0520-2024 | Class II | Para-Pak Zn-PVA/10% Formalin-for the routine co... | Oct 19, 2023 |
| Z-0521-2024 | Class II | Cardinal Health Clean Stool Transportation Syst... | Oct 19, 2023 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.